Physician

Jack F Freidel, MD

According to 2025 Medicare claims, Jack Freidel, MD (NPI: 1487622551) practices family practice in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47001-1378. Freidel is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Freidel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 217 traditional Medicare patients, billed 4,142 HCPCS/CPT codes, and received $116,376 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,173 prescription claims across 370 beneficiaries totaling $788,600 in drug costs, led by Eliquis (Apixaban). DME data shows 59 claims. Open Payments data shows 69 records totaling $1,132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $135,307 and ending at $116,376. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $14,402 and ending at $29,569.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	433	3,669	$135,307
2016	398	3,638	$151,231
2017	386	3,274	$114,273
2018	370	3,006	$109,088
2019	342	3,057	$109,189
2020	308	2,668	$84,705
2021	331	5,822	$182,310
2022	303	4,791	$177,862
2023	232	3,010	$130,134
2024	217	4,142	$116,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	447	11,562	$663,143
2016	445	11,446	$713,719
2017	451	11,256	$705,153
2018	435	10,774	$724,986
2019	410	9,735	$738,010
2020	408	9,336	$755,128
2021	436	8,431	$733,692
2022	442	8,676	$858,548
2023	391	8,251	$891,303
2024	370	8,173	$788,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	77	474	$15,646
2016	92	406	$9,447
2017	64	310	$6,450
2018	50	265	$3,854
2019	33	211	$3,437
2020	16	239	$6,658
2021	12	111	$5,744
2022	13	64	$5,687
2023	N/R	93	$9,626
2024	N/R	59	$12,647

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	147	147	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	195	541	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	157	446	$60
G0008	Administration of influenza virus vaccine	72	75	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	104	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	80	5,007	$96,414
Ozempic	Semaglutide	50	1,934	$61,118
Mounjaro	Tirzepatide	47	1,484	$53,383
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	2,520	$52,145
Jardiance	Empagliflozin	42	2,590	$51,375

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	43	$12,348
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	16	$299

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,132	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jack F. Freidel, MD?

Tedicare shows public-source Medicare data for Jack F. Freidel, MD (NPI 1487622551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jack F. Freidel, MD have ACO affiliation data?

Jack F. Freidel, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Jack F. Freidel, MD?

Jack F. Freidel, MD is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Jack F. Freidel, MD have Open Payments data?

Jack F. Freidel, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.